Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL
Randomized, Double Blinded Phase III Trial of Cisplatin and Etoposide plus Thoracic Radiation Therapy Followed by Nivolumab/Placebo for Unresectable Locally Advanced Non-Small Cell Lung Cancer
Primary Objective
• To compare the overall snrvival (OS) for patients with Stage III nmesectable nonsmall lung cancer treated with or without nivolumab following concurrent chemoradiation.
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/17 → 11/28/18 |
Funding
- RTOG Foundation Incorporated: $15,800.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.